Antifibrinolytics in the treatment of subarachnoid hemorrhages due to ruptured aneurysms.
D000614:Aminocaproates / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D007611:Aprotinin / Q000008:administration & dosage / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D002532:Intracranial Aneurysm / Q000150:complications*; D012422:Rupture, Spontaneous / Q000150:complications; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D014148:Tranexamic Acid / Q000008:administration & dosage / Q000627:therapeutic use
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D004338:Drug Combinations; D014148:Tranexamic Acid; D007611:Aprotinin